Over 30 years of Start-Up to IPO international medical businesses including market research, clinical trials, market strategy development and execution, and establishing and managing high performance direct foreign operations, joint ventures, and specialty distributors in Europe, Middle East, South America, and Asia/Pacific region.
Translational Cancer Informatics Specialist with over 20 years of academic research, public sector, and industry experience.
Oncologist And Director Of Clinical Research Programs for Johns Hopkins Kimmel Cancer Center.
Over 30 years of Start-Up to IPO international medical businesses including market research, clinical trials, market strategy development and execution, and establishing and managing high performance direct foreign operations, joint ventures, and specialty distributors in Europe, Middle East, South America, and Asia/Pacific region.
Andrew is a serial entrepreneur and investor working with the best minds in government and industry, helping to build data-driven solutions for the complex international challenges of our era. Andrew is an accomplished sales leader in federal and large multinational corporations, and his technology expertise is in AI/ML, DevSecOps, and Quantum Information Systems.
Serial entrepreneur and technology investor. Einaras founded CUJO AI to secure everything that connects to the internet, becoming by far the biggest IoT security company protecting more than 1.5 billion devices and 40 million homes. Notable Achievements: Founded, led CUJO AI to become the largest IoT security firm in the world. Named a “Technology Pioneer” by the World Economic Forum and invited to attend Davos in 2019. Named a “Global Innovator” by The World Economic Forum in 2020.
Dr. Nan Hayworth is a Business Development Advisor with Pilot Growth Equity, and a Consulting Medical Director in healthcare communications and special projects for The Kinetix Group. She graduated from Princeton University with an A.B. in biology. She then studied at Cornell University Medical College, after which she trained in ophthalmology at Mount Sinai Hospital, New York. Nan practiced ophthalmology for 16 years in Mount Kisco, New York, growing her own solo practice for several years before being a partner in the Mount Kisco Medical Group (now CareMount Medical). She has been honored by being made an Assistant Clinical Professor at Mount Sinai Hospital as well as by being named to many “Best Doctors” lists. She then went on to serve as a vice president and medical director at Cline Davis & Mann, a healthcare communications agency in New York, and a division of Omnicom, where her client was Genentech. Nan is the only woman physician in history to be elected a voting Member of the House of Representatives, serving the 19th District of New York in the 112th Congress.
Yehuda Neuberger is the President of Brownstone Recovery Group. Neuberger is an active private equity investor with investments in a range of companies in various sectors including financial services, back office processing, and business software. Neuberger serves on the boards of directors for many companies and not-for-profit institutions, including publicly-held Maiden Holdings. From 2001 to 2008, Neuberger was Executive Vice President of American Stock Transfer & Trust Company, and continues to serve on its board and on the board of its international parent, Armor Holdco. Prior to that, Neuberger was an attorney with the firm of Weil, Gotshal & Manges, LLP. Neuberger is a graduate of Johns Hopkins University and Harvard Law School.
Margot Schoenborn is Vice President, Head of Oncology Strategy & Business Management for Laboratory Corporation of America Holdings (“Labcorp”) (NYSE:LH), and S&P 500 company headquartered in Burlington, North Carolina. Margot is responsible for driving the oncology strategy across drug development and diagnostic segments and manages the precision medicine drug development sales and client services teams. Margot joined Labcorp in July 2021 through its acquisition of OmniSeq, Inc., where she served as Chief Executive Officer and Board Director from May 2019 through July 2021. Margot was part of the Roswell Park Comprehensive Cancer Center team, where she served as Deputy General Counsel, that spun out OmniSeq in 2015, and held roles as OmniSeq’s CAO & General Counsel from 2015 through her appointment as CEO of OmniSeq in 2019 after OmniSeq secured its Series B funding. Margot continued as VP, Head of OmniSeq through December 2022 when OmniSeq was fully integrated into Labcorp. Margot is a seasoned business executive and attorney with experience in corporate development, transactions, capital market activities, corporate finance, and leadership of multi-functional teams over 20+ year career in healthcare, state and federal healthcare law enforcement, and commercial litigation. Margot received her JD, cum laude, from University at Buffalo School of Law, where she served as Editor in Chief of the Human Rights Law Review. Margot received her bachelor degree cum laude from Nazareth College. Margot lives in Buffalo, New York with her husband, Jeff, and their two boys.
